Cytokine-induced mechanisms of osteopenic syndrome in the chronic obstructive pulmonary disease (COPD)

E. A. Kochetkova, B. I. Geltser, T. N. Sourovenko, M. V. Volkova, E. E. Peteshova (Vladivostok, Russia)

Source: Annual Congress 2001 - COPD
Session: COPD
Session type: Thematic Poster Session
Number: 1497
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. A. Kochetkova, B. I. Geltser, T. N. Sourovenko, M. V. Volkova, E. E. Peteshova (Vladivostok, Russia). Cytokine-induced mechanisms of osteopenic syndrome in the chronic obstructive pulmonary disease (COPD). Eur Respir J 2001; 16: Suppl. 31, 1497

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Accelerated ageing and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003


Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Osteoporosis in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 64S-75S
Year: 2003



Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 89s
Year: 2002

Chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MS)
Source: Eur Respir J 2006; 28: Suppl. 50, 249s
Year: 2006

Metabolic syndrome in chronic obstructive pulmonary disease
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018

Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008


Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003



Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006


Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002

Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD)
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007


Disease of the airways in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 41S-49S
Year: 2001



Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2008 - Pathophysiology of respiratory diseases
Year: 2008


Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002